FIELD: medicine; pharmaceuticals.
SUBSTANCE: in the context of the present invention, there are disclosed compositions containing Plinabulin and at least one inhibitor of an immune response check point for treating cancer. In some versions of the invention there are presented methods of treating cancer by combined administration of Plinabulin and at least one inhibitor of an immune response control point to a subject in need thereof.
EFFECT: what is presented is the use of Plinabulin in combination with the immune response control point inhibitors.
29 cl, 7 ex, 15 dwg
| Title |
Year |
Author |
Number |
| COMPOSITIONS CONTAINING TUCARESOL OR ANALOGUES THEREOF |
2017 |
- Khuan Lan
- Mokhanlal Ramon
- Llojd Dzhordzh Kennet
|
RU2753543C1 |
| CONTROL POINT INHIBITOR AND WHOLE MYCOBACTERIAL CELLS FOR USE IN CANCER THERAPY |
2016 |
- Akle Charles
- Brunet Laura Rosa
|
RU2733033C2 |
| NOVEL APPROACH TO CANCER TREATMENT USING IMMUNOMODULATION |
2016 |
- Mehta, Vimal D.
- Rastelli, Luca
- Sapra, Aparna Katoch
|
RU2817047C2 |
| NEW APPROACH TO TREATING CANCER WITH APPLICATION OF IMMUNOMODULATION |
2016 |
- Mehta, Vimal D.
- Rastelli, Luca
- Sapra, Aparna Katoch
|
RU2711380C2 |
| CONTROL POINT INHIBITOR AND WHOLE-CELL MICROBACTERIA FOR USE IN TREATING ONCOLOGICAL DISEASE |
2014 |
- Ekl Charlz
- Grendzh Dzhon
- Bilyard Kevin
|
RU2719934C2 |
| COMPOSITION FOR PREVENTING OR TREATING MALIGNANT TUMOUR, COMPRISING AGENT DESTROYING VESSELS, AND IMMUNE CONTROL POINT INHIBITOR |
2018 |
- Kim, Soo Jin
- Kim, U Ji
- Choi, Inhak
- Im, Suna
|
RU2738369C1 |
| CANCER THERAPY BY COMBINED USE OF ONCOLYTIC SMALLPOX VACCINE VIRUS AND IMMUNE CONTROL POINT INHIBITOR, AND PHARMACEUTICAL COMPOSITION AND COMBINED DRUG FOR USE IN CANCER THERAPY |
2019 |
- Nakao Shinsuke
- Kawase Tatsuya
|
RU2788874C2 |
| BISPECIFIC ANTIBODIES TO CD25 AND Fc GAMMA-RECEPTOR FOR ELIMINATION OF TUMOR-SPECIFIC CELLS |
2017 |
- Kezada, Serkhio
- Peggs, Karl
- Arse Vargas, Frederik
|
RU2759970C2 |
| METHODS AND COMPOSITIONS FOR TUSC2-IMMUNOTHERAPY |
2017 |
|
RU2755903C2 |
| COMBINATION THERAPY WITH A CHEMOKINE RECEPTOR 2 (CCR2) ANTAGONIST AND A PD-1/PD-L1 INHIBITOR |
2018 |
- Campbell, James J.
- Miao, Zhenhua
- Schall, Thomas J.
- Charo, Israel
- Li, Shijie
- Janson, Christine Marie
- Singh, Rajinder
- Ebsworth, Karen
|
RU2796863C2 |
